Recent Blog Posts

View Post: Treatment of Feline Diabetes
5 Nov 2009 by winn@winnfelinehealth.org (Winn Feline Foundation)  
Hall, TD, et al., Effects of diet on glucose control in cats with diabetes mellitus treated with twice daily insulin glargine. Journal of Feline Medicine & Surgery, 2009. 11(2): p. 125-130. >> PubMed Abstract ...
View Blog: Cat Health News from the Winn Feline Foundation - http://winnfelinehealth.blogspot.com/

---

View Post: Insulin Glargine Safety in Pregnancy: a Transplacental Transfer ...
6 Oct 2009 by Pollex, EK, Feig, DS, Lubetsky, A., Yip,...  
Objective: Insulin glargine (Lantus, Aventis Pharmaceuticals) is an extended-action insulin analogue with greater stability and duration of action compared to regular human insulin. The long duration of action and decreased incidence of ...
View Blog: Diabetes Care Journal publish ahead of... - http://care.diabetesjournals.org/

---

View Post: New data shows that type 2 diabetes patients who start insulin ...
2 Oct 2009 by insciences  
Once Daily Initiation with NovoMix 30 versus Insulin Glargine in Patients with Type 2 Diabetes Inadequately Controlled with Oral Drugs – a Randomized Controlled Trial. European Association for the Study of Diabetes 45th Annual Meeting, ...
View Blog: Articles - http://insciences.org/articles.php

---

View Post: Insulin glargine and cancer: Association, but no causal link
2 Oct 2009
Presenting at the European Association for the Study of Diabetes (EASD) 2009 Meeting, six experts commented on the potential link between insulin and insulin analogs—and specifically insulin glargine—and cancer. Current president of the ...
View Blog: theHeart.org - http://www.theheart.org/

---

View Post: Roche , Ipsen Diabetes Drug Meets Late-Stage Target - News, Search ...
30 Oct 2009
Four of the eight studies have active comparators, including exenatide, sitagliptin, insulin glargine and pioglitazone. About Taspoglutide (R1583). Taspoglutide was selected from a family of human once-weekly long-acting glucagon-like ...
View Blog: BioSpace.com Featured News and Stories - http://www.biospace.com/

---

View Post: EASD: Insulin Analogues, Cancer Linked, but No Causality Shown
3 Oct 2009
Patients taking insulin-based drugs for diabetes appear prone to increased rates of cancer diagnosis, but there appears to be no special risk for insulin glargine (Lantus) compared with other insulins, researchers said. ...
View Blog: Diabetes In Control News - http://www.diabetesincontrol.com/index.php?option=com_content&view=art...

---

View Post: No conclusive evidence linking insulin glargine to higher cancer risk
3 Nov 2009
Insulin glargine (brand name: Lantus) is used once daily for control of diabetes, often in combination with a short acting sulfonylurea or other insulin. Medsafe and the Medicines Adverse Reactions Committee (MARC) have reviewed the ...
View Blog: NZ Ministry of Health - http://www.moh.govt.nz/moh.nsf

---

View Post: Novo Nordisk's anti-diabetes drug liraglutide (Victoza) helps lose ...
23 Oct 2009 by pillscribe  
Furthermore, total cholesterol and low density lipoproteins were significantly reduced with liraglutide treatment compared to rosiglitazone, glimepiride or insulin glargine. In the meta-analysis evaluating efficacy on combined treatment ...
View Blog: DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/

---